Global Big Data Players in Healthcare 2017 Featuring Google, Apple, IBM Watson and Other IT Companies

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

The "Big Data in Healthcare 2017" report has been added to Research and Markets' offering.

The healthcare industry is currently attempting to restructure itself. The guiding principle of this restructuring: the acquisition and employment of what is known as "Big Data." Big Data consists of the enormous datasets that flow daily from manufacturers, healthcare providers, regulatory bodies, scientists and others. It is a broad term for any collection of information so vast and complex that it can't be handled with traditional data-processing tools.

There is considerable discussion of Big Data in many industries. The healthcare industry is one of the industries in which applications of the concept are arising. Big Data in Healthcare examines selected current and future applications of Big Data within the healthcare ecosystem.

In the Healthcare Field, Multiple Sources of Data may be Available, Including:

• Clinical data, as from medical diagnosis, medical images, patient histories, labs
• Omics data, as from genomics, transcriptomics, proteomics, epigenomics
• Claims data, from health systems and providers, via the processing of public and private claims
• User-generated data, as from fitness apps and data from smartphones

Big Data in Healthcare looks at Contributions and Applications in the Following Healthcare Segments:

• Information Technology in In Vitro Diagnostics
• Personalized Medicine
• Pharmaceutical industry
• Electronic Medical Records (EMR)
• Mobile Health (mHealth)
• Health Insurance Industry

Information Technology (IT) companies participating in in vitro diagnostics (IVD) are diverse and show great ingenuity. In IVD, there has been a proliferation of software options to capture and analyze data from multiplexed, signature panel, mass spectroscopy, arrays and biochip platform molecular acid tests, among others. IVD companies are moving from a device-driven approach to a total systems suite of services approach with a data management focus, illustrated via partnerships with Google, Apple, IBM Watson and other IT companies. Selected applications of Big Data discussed within the report fall into the subsegments of molecular diagnostics, microbiology and virology, histology and cytology, digital imaging, mass spectrometry, and clinical chemistry.

Precision or personalized medicine applications of Big Data are discussed within the report. Big Data will be essential to unlocking precision medicine. By combining tissue data, genomics, and clinical outcomes, doctors will be able to better match therapies with patients.

Big Data in Healthcare also Presents Information on the Following Big Data Developments:

• Selected IVD Industry IT/Big Data Investments
• Selected IT Innovations in Molecular Diagnostics
• Selected Genomic Tests for Inherited Diseases
• Selected Digital Imaging Innovations
• Selected Collaborations between Pharmaceutical and Diagnostic Companies
• Selected Insurance Industry Big Data Initiatives
• Selected Big Data Alliances and Organizations

Company profiles within the report look at Big Data players. Big Data players, defined broadly for the purposes of the report, are companies or organizations involved with healthcare analytics processes in some form, whether gathering healthcare data, either in an unstructured or a structured (as in an EHR platform) way; structuring healthcare data; or applying healthcare data, as is most often the case in precision medicine applications.

The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.

Key Topics Covered:

1: Executive Summary

• Introduction
• Information Technology In In Vitro Diagnostics
• IBM Watson
• Molecular Diagnostics
• Personalized Medicine
• Pharma
• Electronic Medical Records (EMR)
• Contribution Of Health Insurance Companies
• Methodology

2: The Healthcare Market'S Response To Big Data Issues

• Overview
• In Vitro Diagnostics
• Digital Technology, IT
• Table 2-1: Selected IVD Industry It/Big Data Investments
• Molecular Diagnostics
• Table 2-2: Selected It Innovations In Molecular Diagnostics
• Table 2-3: Selected Genomic Tests For Inherited Diseases
• Microbiology And Virology
• Histology And Cytology
• Selected Digital Imaging Innovations
• Table 2-4: Selected Digital Imaging Innovations
• Mass Spectrometry
• Clinical Chemistry
• Precision Or Personalized Medicine
• Pharma
• Pfizer, Novartis, And Thermo Fisher Collaborate
• Abbvie, Amgen, And BMS
• Abbvie's Global Research Collaborations
• Eli Lilly
• Project Data Sphere
• Genentech
• Pfizer And Noux
• Merck Works To Optimize Vaccine Yields
• Collaborations Between Pharmaceutical And Diagnostic Companies
• Table 2-5: Selected Collaborations Between Pharmaceutical And Diagnostic Companies
• Electronic Medical Records (EMR)
• Connectivity
• Radical Product Innovations: Dashboard Modules, Usability, Tablets, E-Prescribe, Big Data
• Usability Is A Must
• Data Storage Concerns - Top Focus
• Tablet-Focus Essential For EMR Vendors
• CPOE And Other Features Sell EMR Systems
• Mobile Health (Mhealth)
• Contributions Of Health Insurance Companies
• Table 2-6: Selected Insurance Industry Big Data Initiatives
• Selected Big Data Alliances And Organizations
• Table 2-7: Selected Big Data Alliances And Organizations

3: Selected Big Data Players

• Advancemd
• Allscripts Healthcare Solutions
• Company Overview
• Company Financials
• Amazon
• Company Overview
• Amazon's Possible Entrance Into The Healthcare Industry
• Other Company News
• Apple Inc.
• Athenahealth, Inc
• Company Overview
• Company Financials
• BGI (Formerly Beijing Genomics Institute)
• Prenatal Testing
• Liquid Biopsy
• With Complete Genomics
• BGI Projects
• Bina Technologies, Inc. (Part Of Roche Sequencing)
• Cerner Corporation
• Company Overview
• Molecular Test Data For Personalized Medicine
• Strategy For Growth
• Company Financials
• CLC Bio (A Qiagen Company)
• Definiens
• Dell Healthcare And Life Sciences
• Eclinicalworks
• Company Overview
• Company Financials
• Epic Systems Corporation
• Company Overview
• Company Financials
• GE Healthcare
• Company Overview
• Company Financials
• Genalice
• Genomoncology
• Google Genomics (Alphabet)
• Hewlett Packard
• IBM Healthcare
• Illumina, Inc.
• Acquisitions And Investments
• Intel Corporation
• Intersystems Corporation
• IVD Industry Connectivity Consortium - IICC
• Knome Inc.
• Collaborations
• Leica Biosystems (Danaher)
• Mayo Medical Laboratories
• Information Technology
• Mckesson Corporation
• Company Overview
• Company Financials
• Medical Information Technology, Inc. (Meditech)
• Company Overview
• Company Financials
• Microsoft
• Overview
• .Net
• Healthcare Next
• Other Initiatives
• N-Of-One
• Oracle Corporation
• Company Overview
• Healthcare Solutions
• Palantir
• Pathway Genomics Corporation
• Perkinelmer
• Quality Systems, Inc. (QSI)
• Company Overview
• Company Financials
• Quest Diagnostics, Inc.
• Products And Services
• Partnerships
• Roche Diagnostics
• The Connected Lab
• Big Data And Type 2 Diabetes
• Selected Agreements And Acquisitions
• Sap SE
• Company Overview
• Company Financials
• Selventa, Inc.
• Company Overview
• Autoimmune IVD Products
• Sunquest Information Systems
• Wuxi Nextcode Genomics

For more information about this report visit: https://www.researchandmarkets.com/research/9m5wv4/big_data_in

Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716